ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2025
Expert transvaginal ultrasound is determinant for diagnosing pelvic conditions after recurrent implantation failure in IVF.
Article in European journal of obstetrics & gynecology and reproductive biology: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Proposals for the #Enzian addendum and update: an international expert survey for item generation.Facts, views & vision in ObGyn · 2026Article
- Optimizing the Endometrial Factor in Recurrent Implantation Failure: From Established Diagnostics to Mechanism-Informed Management.Journal of clinical medicine · 2026Review
- Medical Treatment for Endometriosis: One Size Does Not Fit All.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Recurrent implantation failure (RIF) is a clinical phenomenon characterized by a lack of implantation after several embryo-transfers. The aim of this study was to evaluate missing pelvic pathologies in patients with RIF, following at least two embryo-transfers of good-quality blastocyst, using a dedicated transvaginal ultrasound (TVS) performed by experienced specialists. Methods: This retrospective study included patients with RIF who were admitted to the Gynecological Ultrasound Unit of the University of Rome 'Tor Vergata' between 2020 and 2024 for a second-opinion ultrasound. Only patients with transfers of euploid blastocysts and/or blastocysts from oocytes donation were included. All patients underwent 2D, 3D and Power-Doppler transvaginal examination to evaluate all possible pelvic pathologies. Results: The study included 152 patients who met the inclusion criteria. Pathological pelvic findings were identified in 45 of 152 women during the initial TVS scans performed at the IVF centres before ET, whereas expert TVS evaluation at our center after RIF diagnosed pelvic pathology in 129 of 152 cases (p < 0.0001). Significant differences were observed for all pathological ultrasound findings between the initial IVF center scan and the expert TVS, except for isthmocele. In particular, the lowest overall agreement (OA), Cohen's Kappa (K) and positive percent agreement (PPA) was described regarding the diagnosis of adenomyosis, uterine malformations, hydrosalpinx and deep infiltrated endometriosis. Conclusion: Our study revealed a significant discrepancy in the diagnosis of ultrasound-detectable pelvic pathologies between IVF centres and our expert gynecological ultrasound unit. This difference highlights the potential underdiagnosis of critical pelvic conditions when ultrasound is performed by not expert sonographers in IVF centres.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.